Saltar al contenido
Merck

Evidence for a direct link between PAD4-mediated citrullination and the oxidative burst in human neutrophils.

Scientific reports (2018-10-17)
Yebin Zhou, Ling-Ling An, Raghothama Chaerkady, Nanette Mittereder, Lori Clarke, Taylor S Cohen, Bo Chen, Sonja Hess, Gary P Sims, Tomas Mustelin
RESUMEN

Neutrophils are critical for the defense against pathogens, in part through the extrusion of extracellular DNA traps, phagocytosis, and the production of reactive oxygen species. Neutrophils may also play an important role in the pathogenesis of rheumatoid arthritis (RA) through the activation of protein arginine deiminases (PADs) that citrullinate proteins that subsequently act as autoantigens. We report that PAD4 is physically associated with the cytosolic subunits of the oxidative burst machinery, p47phox (also known as neutrophil cytosol factor 1, NCF1) and p67phox (NCF2). Activation of PAD4 by membranolytic insults that result in high levels of intracellular calcium (higher than physiological neutrophil activation) leads to rapid citrullination of p47phox/NCF1 and p67phox/NCF2, as well as their dissociation from PAD4. This dissociation prevents the assembly of an active NADPH oxidase complex and an oxidative burst in neutrophils stimulated by phorbol-ester or immune complexes. In further support of a substrate-to-inactive enzyme interaction, small-molecule PAD inhibitors also disrupt the PAD4-NCF complex and reduce oxidase activation and phagocytic killing of Staphylococcus aureus. This novel role of PAD4 in the regulation of neutrophil physiology suggests that targeting PAD4 with active site inhibitors for the treatment of RA may have a broader impact on neutrophil biology than just inhibition of citrullination.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Diphenyleneiodonium chloride, ≥98%
Sigma-Aldrich
Anti-Protein-arginine deiminase 4 Antibody, clone 10F1, clone 10F1, from mouse